Navigation Links
Musculoskeletal center wins $2.2 million for drug safety
Date:11/18/2008

range of autoimmune disorders. Among the studied drugs is what's called anti-TNF agents, or anti-tumor necrosis factor alpha agents. This category includes adalimumab (Humira), etanercept (Enbrel) and infliximab (Remicade). Five additional biologics will be studied.

The analysis will include patients who live in rural areas, and those who've been diagnosed with more than one autoimmune illness. Data will come from more than 100,000 biologics patients in the period 1998 to 2007.

The biologics study will include researchers from Brigham and Women's Hospital in Boston, Kaiser Permanente's Division of Research in California, Oregon Health and Science University in Portland, the University of Massachusetts Medical Center in Worcester, the University of Pennsylvania in Philadelphia and Vanderbilt University in Nashville.


'/>"/>

Contact: Troy Goodman
tdgoodman@uab.edu
205-934-8938
University of Alabama at Birmingham
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Georgia Tech/Emory Center to study origin of life
2. Woods Hole Research Center to lead undergraduate initiative in the Siberian Arctic
3. $10 million gift to support cutting-edge epigenome center at USC
4. 3 Columbia University Medical Center faculty elected to Institute of Medicine
5. NHGRI funds new Centers for Excellence in Ethical, Legal and Social Implications Research
6. NYUs Center for Genomics & Systems Biology receives $4.4 million NSF grant
7. Monsanto expands sponsorship for Peking-Yale Joint Agrobiotechnology Center
8. Woods Hole Research Center debuts new image mosaic that will strengthen global forest monitoring
9. DFG to establish 10 new collaborative research centers
10. Ireland Cancer Center researchers advance stem cell gene therapy
11. Manomet Center awarded major NFWF grant to foster shorebird conservation

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)... Lowly bacteria, it turns out, hold the power to h...around the world clean up toxic waste on test site... RDX, were invented back in World War II and have ...e high-energy compounds are often used to propel t... TNT. , But with increased knowledge of their ...
(Date:11/4/2009)...Y, Calif., Oct. 20 DigitalPersona,...tication solutions, today announced that WAND Corp... software for quick-service restaurants, has integ... POS and Classic POS solutions. WAND,s quick-servi... boost cashier accountability and deter unauthoriz...
(Date:11/4/2009)...ct. 27 Global Rainmakers, Inc., an...d R&D laboratory, today announced that the com... to actively commercialize its suite of technologi...urity offerings. ,, During the past four years,... to develop and deploy a series of core--but expan...
Breaking Biology News(10 mins):Genomic research will enable greener cleanup of military explosive test sites 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 2Global Rainmakers Brings Cutting-Edge Biometric Security Products to Reality 3Bionovo to Present at the BMO Capital Markets Ninth Annual Focus on Healthcare Conference 53067 1Bionovo to Present at the BMO Capital Markets Ninth Annual Focus on Healthcare Conference 53067 2Patriot Scientific Corporation Announces Cardiac Science Corporations Purchase of a Moore Microprocessor Patent 28TM 29 Portfolio License 53064 1Patriot Scientific Corporation Announces Cardiac Science Corporations Purchase of a Moore Microprocessor Patent 28TM 29 Portfolio License 53064 2Prioritize Pregnant Women to Get Swine Flu Shot Experts Say 53061 1Prioritize Pregnant Women to Get Swine Flu Shot Experts Say 53061 2Prioritize Pregnant Women to Get Swine Flu Shot Experts Say 53061 3Prioritize Pregnant Women to Get Swine Flu Shot Experts Say 53061 4
...ipoprotein (LDL), a transporter of cholesterol, ma...usly unidentified mechanism, according to a report...tudy reveals a link between native LDL (nLDL) and ...(VEGFR1), which plays a central role in blood vess...ng cholesterol from the liver to peripheral tissue...
...N. -- Kansas State University was awarded a three-...tudy the social, cultural and economic impacts of ...Kansas and Iowa. The $696,827 grant comes from the...ions of Research on Alternative Bioenergy Technolo...m. The researchers from K-State,s department of so...
...t the cutting edge of surgery., From cosmetic to b...gradually replacing the steel scalpel for many pro...e is still a lot that scientists do not know about...ng tissue. Now, some of these basic questions have...ltraviolet lasers similar to those used in LASIK ...
Other Biology News:K-State sociologists use Department of Energy grant 2New insights into how lasers cut flesh 2New insights into how lasers cut flesh 3
(Date:11/6/2009)...6 Intarcia Therapeutics, Inc. deli...OS® continuous delivery of exenatide) program... Annual Diabetes Technology Meeting in San Francis...in/prnh/20050301/SFTU126LOGO ) ,, Continuous ...wers Plasma Glucose, HbA1c and Reduces Weight in a...
(Date:11/5/2009)... 5 DSM Pharmaceutical Products tod...ance with Galenix, Saint Jean D,Illac, France, whe...facturing partner for Galenix commercial products ...aborate on business development opportunities co-m... on the strength of Galenix in drug product develo...
(Date:11/5/2009)... BioSpecifics Technologi...pany developing first-in-class collagenase-based p... the third quarter ended September 30, 2009. ,...his year, the FDA,s Arthritis Advisory Committee u...roval of XIAFLEX(TM) for the treatment of Dupuytre...
(Date:11/5/2009)... SpineSmith Partners has signed an ...p a unique scaffold that mimics the structure of n...everal commercial products by SpineSmith,s Researc... the GenOsteo scaffold represents a significant ad...ideal environment for the delivery of adult stem c...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2
...oronis Pharmaceuticals, Inc., a,biotechnology comp...eutics,today announced the appointment of David Dr...eske brings more than a decade of business develop...formerly served as Vice President of,Business Deve...echnology,company, from 2004 to 2006. While at Hel...
...e for Year on Higher Services Revenues, Lower Expe...(Nasdaq: DRAD ), a leading provider of medical di...s, offices, hospitals and imaging centers, today,r...d December 31, 2007, on,higher annual revenues and...ated revenues for the quarter were $18.8 million, ...
...the London School of Economics and Political Scien...te (ELI) and the Project on Emerging Nanotechnolog...tional Center for Scholars and The Pew Charitable ...ission grant to conduct an international research ...pean Union and United States ( www.lse.ac.uk/nanor...
Other Biology Technology:Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months 2Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months 3Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months 4Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months 5Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months 6Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months 7European Commission gives grant to investigate transatlantic oversight of nanotech 2European Commission gives grant to investigate transatlantic oversight of nanotech 3
NucBuster Protein Extraction Kit from Novagen
... Synthetic peptide derived from the C-terminal reg...actor D iris-expressed growth factor spinal cord-d... mouse and rat by one amino acid replacement. Spe...rat PDGF-D proteins. Reactivity: Human (positive ...
Rabbit anti-USP33 AbVantage Pack Polyclonal Antibody, Unconjugated from Bethyl Laboratories
Normal Rabbit Serum from Calbiochem
Biology Products: